Financhill
Back

Edwards Lifesciences Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
23

EW
Edwards Lifesciences

Last Price:
66.48
Seasonality Move:
7.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Edwards Lifesciences Price Quote

$66.48
-1.06 (-1.57%)
(Updated: November 4, 2024 at 5:55 PM ET)

Edwards Lifesciences Key Stats

Sell
23
Edwards Lifesciences (EW) is a Sell

Day range:
$66.67 - $68.59
52-week range:
$58.93 - $96.12
Dividend yield:
0%
P/E ratio:
29.37
P/S ratio:
6.94
P/B ratio:
5.47%

Volume:
4M
Avg. volume:
6.1M
1-year change:
5.81%
Market cap:
$40.7B
Revenue:
$6B
EPS:
$6.93

How Much Does Edwards Lifesciences Make?

Is Edwards Lifesciences Growing As A Company?

  • What Is Edwards Lifesciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.09%
  • What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 7.14%

Edwards Lifesciences Stock Price Performance

What Is Edwards Lifesciences 52-Week High & Low?

Edwards Lifesciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Edwards Lifesciences?

Is Edwards Lifesciences Cash Flow Positive?

  • What Is EW Cash Flow From Operations?
    Cash flow from operations (TTM) is $866.1M
  • What Is Edwards Lifesciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$591.4M
  • What Is Edwards Lifesciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $291M

Edwards Lifesciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EW return on invested capital is 54.5%
  • What Is Edwards Lifesciences Return On Assets?
    ROA measures how assets are converting to revenues and is 43.13%
  • What Is EW Return On Equity?
    ROE is a measure of profitability and is 21.3%

Edwards Lifesciences Earnings Date & Stock Price

Edwards Lifesciences Competitors

Edwards Lifesciences Dividend Yield

Edwards Lifesciences Analyst Estimates

YoY Growth Past Surprise
EPS: 714.29% 13.97%
Revenue: -8.54% -1.01%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 19
Sell Recommendations: 0
Price Target: 76.36
Upside from Last Price: 13.05%

Major Shareholders

  • How many EW shares are owned by institutional investors?
    779.2M EW shares are owned by institutional investors
  • How many EW shares are owned by insiders?
    1.8M EW shares are owned by insiders